(Q39503071)

English

Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

10

object named as

Gero Brockhoff

0 references

author name string

Tobias Ach

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Katharina Zeitler

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Stephan Schwarz-Furlan

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Katharina Baader

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Abbas Agaimy

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Christian Rohrmeier

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Johannes Zenk

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Martin Gosau

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Torsten E Reichert

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Gero Brockhoff

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Tobias Ettl

11

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

15 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Virchows Archiv

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

462

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

65-72

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Met, metastasis, motility and more

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Prognostic value of a three-grade classification in primary epithelial parotid carcinoma: result of a histological review from a 20-year experience of total parotidectomy with neck dissection in a single institution

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Salivary gland mucoepidermoid carcinoma is a clinically, morphologically and genetically heterogeneous entity: a clinicopathological study of 40 cases with emphasis on grading, histological variants and presence of the t(11;19) translocation.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Molecular cloning of a new transforming gene from a chemically transformed human cell line.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

EGFR and HER2-Akt-mTOR signaling pathways are activated in subgroups of salivary gland carcinomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Hepatocyte growth factor and c-Met (HGF/c-Met) in adenoid cystic carcinoma of the human salivary gland

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

CD151 forms a functional complex with c-Met in human salivary gland cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

MET tyrosine kinase inhibitor crizotinib (PF-02341066) shows differential antitumor effects in non-small cell lung cancer according to MET alterations

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Salivary duct carcinoma: targeting the phosphatidylinositol 3-kinase pathway by blocking mammalian target of rapamycin with temsirolimus.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1358-0

21 January 2018

HER3 and mutant EGFR meet MET

1 reference

https://pubmed.ncbi.nlm.nih.gov/23242174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23242174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocyte growth factor and c-Met immunoreactivity are associated with metastasis in high grade salivary gland carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23242174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salivary gland carcinomas--prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23242174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23242174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salivary gland tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/23242174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23242174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/23242174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MET signaling pathway: a rational target for cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23242174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dysregulation of Met receptor tyrosine kinase activity in invasive tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23242174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer--loss of PTEN predicts resistance to treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23242174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00428-012-1358-0

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39503071&oldid=2202934923"